Sethi Prabhdeep S, Hiser William, Gaffar Hasan, Jiang Leng, Islam Ashequl, Bhatnagar Nitin, Slawsky Mara
Department of Cardiology, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199, USA.
Eur J Echocardiogr. 2008 Nov;9(6):819-21. doi: 10.1093/ejechocard/jen180. Epub 2008 Jun 13.
The safety of dobutamine stress echocardiography (DSE) has been demonstrated in multiple studies with a major complication rate of <1%. Specifically, ventricular tachycardia during DSE has a reported incidence of 0.3%, and has been bound to be of no prognostic significance in patients without obstructive coronary artery disease. We report a unique case of fatal pheochromocytoma crisis precipitated by DSE in a patient with heretofore unknown adrenal disease. We are once again reminded that no diagnostic modality is absolutely without risk; however, minimal they might be.
多巴酚丁胺负荷超声心动图（DSE）的安全性已在多项研究中得到证实，主要并发症发生率<1%。具体而言，DSE期间室性心动过速的报告发生率为0.3%，并且在无阻塞性冠状动脉疾病的患者中已被证明无预后意义。我们报告了一例独特的病例，一名患有此前未知肾上腺疾病的患者在DSE后引发了致命的嗜铬细胞瘤危象。我们再次被提醒，没有任何诊断方法是绝对没有风险的；然而，风险可能极小。
